Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Effect van onderbreking methotrexaat op de immuniteit na de COVID-19-booster
jan 2023 | Psoriasis, RA, Vaccinatie, Virale infecties